Core Viewpoint - Kunlun New Materials has submitted an application for a mainboard listing on the Hong Kong Stock Exchange after failing to secure an A-share IPO, facing challenges such as low profit margins, high dependency on major clients, and low R&D investment [1][10]. Group 1: Company Overview - Kunlun New Materials specializes in the research, production, and sales of lithium battery electrolytes, and has expanded into solid-state electrolytes and sodium-ion electrolytes [14]. - The company ranked fifth, fourth, and third among global electrolyte suppliers by shipment volume in 2023, 2024, and the first three quarters of 2025, respectively [15]. Group 2: Financial Performance - Revenue figures for Kunlun New Materials were 1.577 billion yuan, 1.021 billion yuan, and 1.032 billion yuan for the years 2023, 2024, and the first three quarters of 2025, with net profits of 86.168 million yuan, -27.609 million yuan, and -136,000 yuan [15]. - The company's gross margin is approximately one-third of that of its competitor, New Zhongbang, and one-fourth of Tianqi Materials [15]. Group 3: Client Dependency and Market Position - The company heavily relies on major clients, with sales to the top five clients accounting for 82.1%, 73%, and 73% of total revenue in 2023, 2024, and 2025, respectively. Notably, CATL accounted for 60.1%, 59.3%, and 49.6% of total revenue [17]. - The strong position of lithium battery manufacturers and automotive companies in the supply chain limits the bargaining power of electrolyte suppliers like Kunlun New Materials [17]. Group 4: Production Capacity and Expansion Plans - Kunlun New Materials plans to expand its production capacity from 180,000 tons to over 500,000 tons, a nearly threefold increase, despite currently having around 50% of its capacity idle [20][21]. - The company has faced regulatory scrutiny due to aggressive capacity expansion plans and issues related to safety, financial discrepancies, and related party transactions [22]. Group 5: Pricing and Market Sustainability - The price of Kunlun New Materials' electrolyte products has decreased from approximately 30,000 yuan per ton in 2023 to around 17,000 yuan in 2024, and further down to between 14,000 and 17,000 yuan in the first three quarters of 2025, raising concerns about the sustainability of its pricing strategy [19].

Company Overview - The company is a global leader in lithium battery electrolyte supply, focusing on the research, production, and sales of lithium battery electrolytes and advanced battery materials [5] - It has become a rapidly growing electrolyte technology enterprise in China, ranking third among global electrolyte suppliers by shipment volume as of September 30, 2025 [5] - The company has established strategic partnerships with leading global new energy technology companies and maintains close cooperation with downstream customers through early-stage product development and capacity expansion [5] Technological Innovation - The company actively pursues technological innovation in advanced battery materials such as solid-state electrolytes (SSE) and sodium-ion electrolytes, independently developing several technologies [6] - It has achieved an ionic conductivity of 12 mS/cm for its self-developed sulfide SSE, nearing that of liquid electrolytes, and has developed flame-retardant gel electrolytes that enhance battery safety [6] Production Capacity - The company has established strategically located production bases in Zhejiang, Sichuan, and Shandong, with a total electrolyte production capacity of 180,000 tons per year as of January 18, 2026 [8] - Plans are in place to build or expand production bases in Yichang, Jining, Huzhou, Yibin, and Szolnok, Hungary, aiming to exceed a total production capacity of 500,000 tons [8] Financial Performance - Revenue for the nine months ending September 30 was approximately RMB 1.577 billion in 2023, RMB 1.021 billion in 2024, and RMB 1.033 billion in 2025 [10] - The company reported a profit of RMB 86.168 million in 2023, a loss of RMB 27.609 million in 2024, and a loss of RMB 0.136 million in 2025 [11] - Gross margins were 11% in 2023, 4.4% in 2024, and 5.7% in 2025 [12] Industry Overview - The global lithium battery industry is experiencing rapid growth, with shipments expected to rise from 323.2 GWh in 2020 to 1,549.6 GWh in 2024, reflecting a compound annual growth rate (CAGR) of 48% [14] - China remains the largest market, with shipments projected to grow from 142.5 GWh in 2020 to 1,173.0 GWh in 2024, maintaining a CAGR of 69.4% [14] - The electrolyte market is closely tied to the lithium battery industry, with global electrolyte shipments expected to increase from approximately 342,000 tons in 2020 to about 1,509,000 tons in 2024, representing a CAGR of 44.9% [18]

Group 1 - The core viewpoint of the articles is that Kunlun New Energy Materials Technology (Yichang) Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, indicating its growth and strategic positioning in the electrolyte technology sector [1][4] - The company is recognized as a rapidly growing electrolyte technology enterprise in China, with a steadily increasing market share in recent years [1] - According to Frost & Sullivan, the company ranked third among global electrolyte suppliers by shipment volume for the nine months ending September 30, 2025 [1] - The company has strategically positioned itself in advanced battery materials, including solid-state electrolytes (SSE), gel electrolytes, solid-liquid hybrid electrolytes, and sodium-ion electrolytes [1] Group 2 - The company is a global leader in lithium battery electrolyte supply, focusing on the research, development, production, and sales of lithium battery electrolytes and advanced battery materials [4] - The company leverages its technological advantages and strategically laid-out production capacity to provide stable, safe, efficient, and advanced products for the global new energy industry [4]

Core Viewpoint - The company, Fengshan Group, clarifies that its main business remains focused on the production, research, and sales of raw medicines and formulations, despite media reports linking it to the "solid-state battery" concept [1] Business Operations - The company primarily sells lithium-ion electrolytes, with sodium-ion electrolytes making up a very small portion of sales, accounting for only 0.01% of the consolidated revenue by mid-2025 [1] - The collaboration with Tsinghua University, led by Professor Zhang Qiang, is at an early research and development stage, with a small contract amount and a long project timeline extending to December 31, 2028 [1] Research and Development - The research project commissioned by the company is not the same as the significant research results recently published by Professor Zhang's team [1] - There is considerable uncertainty regarding the future research outcomes and their commercialization [1]

Core Viewpoint - Fengshan Group (603810.SH) clarifies that its main business remains focused on the production, research, and sales of raw medicines and formulations, despite media reports linking the company to the "solid-state battery" concept [1] Business Operations - The company emphasizes that its main operations have not changed, and its subsidiary Fengshan Quannuo primarily sells lithium-ion electrolytes, with sodium-ion electrolytes accounting for a relatively small proportion of sales [1] - As of the first half of 2025, sodium-ion electrolyte sales are projected to represent only 0.01% of the company's consolidated revenue [1] Research and Development - The recent important research results published by Professor Zhang Qiang's team from Tsinghua University are not related to the research and development project commissioned by the company [1] - The collaboration with Tsinghua University is still in the preliminary research and development phase, with a small contract amount, and the technical development project is expected to last until December 31, 2028, indicating significant uncertainty regarding future research outcomes and commercialization [1]

Core Viewpoint - Fengshan Group (603810.SH) clarifies that its main business remains focused on the production, research, and sales of raw medicines and formulations, despite media reports linking the company to the "solid-state battery" concept [1] Business Operations - The company’s main business has not changed, and its subsidiary Fengshan Quannuo primarily sells lithium-ion electrolytes, with sodium-ion electrolytes accounting for a relatively small proportion of sales [1] - As of the first half of 2025, sodium-ion electrolyte sales are expected to represent only 0.01% of the company’s consolidated revenue [1] Research and Development - The important research results published by Professor Zhang Qiang's team from Tsinghua University are not related to the research and development project commissioned by the company [1] - The collaboration with Tsinghua University is still in the preliminary research and development phase, with a small contract amount, and the technical development project is scheduled to last until December 31, 2028, indicating significant uncertainty regarding future research outcomes and commercialization [1]

Core Viewpoint - The company, Fengshan Group (603810.SH), clarifies that its main business remains focused on the production, research, and sales of raw medicines and formulations, despite recent media reports linking it to the "solid-state battery" concept [1] Business Operations - The company’s main business has not changed, and its subsidiary, Fengshan Quannuo, primarily sells lithium-ion electrolytes, with sodium-ion electrolytes making up a relatively small portion of sales [1] - As of the first half of 2025, sodium-ion electrolyte sales are expected to account for only 0.01% of the company's consolidated revenue [1] Research and Development - The important research results published by Professor Zhang Qiang's team from Tsinghua University are not related to the research and development project commissioned by the company [1] - The collaboration with Tsinghua University is still in the preliminary research and development phase, with a small contract amount, and the technical development project is scheduled to last until December 31, 2028 [1] - There is significant uncertainty regarding the subsequent research outcomes and their commercialization [1]

Core Viewpoint - The company clarifies that its main business remains focused on the production, research, and sales of raw medicines and formulations, despite media reports linking it to the "solid-state battery" concept [1] Business Operations - The company's main business has not changed, and its subsidiary, Fengshan Quannuo, primarily sells lithium-ion electrolytes, with sodium-ion electrolytes making up a relatively small portion of sales [1] - As of the first half of 2025, sodium-ion electrolyte sales are expected to account for only 0.01% of the company's consolidated revenue [1] Research and Development - The important research results published by Professor Zhang Qiang's team from Tsinghua University are not related to the company's commissioned research and development project [1] - The collaboration with Tsinghua University is currently in the preliminary research and development phase, with a small contract amount, and the technology development project is scheduled to last until December 31, 2028 [1] - There is significant uncertainty regarding the subsequent research outcomes and their commercialization [1]

Core Viewpoint - The company, Fengshan Group, clarifies that its main business remains focused on the production, research, and sales of raw medicines and formulations, despite recent media speculation linking it to the "solid-state battery" concept [1] Business Operations - The company’s main business has not changed, and its subsidiary, Fengshan Quannuo, primarily sells lithium-ion electrolytes, with sodium-ion electrolytes accounting for a relatively small proportion of sales [1] - As of the first half of 2025, the sales revenue from sodium-ion electrolytes is expected to represent only 0.01% of the company's consolidated operating income [1] Research and Development - The recent important research results published by Professor Zhang Qiang's team from Tsinghua University are not related to the research and development project commissioned by the company [1] - The collaboration with Tsinghua University is still in the preliminary research and development phase, with a small contract amount, and the technical development project is scheduled to last until December 31, 2028 [1] - There is significant uncertainty regarding the subsequent research outcomes and their commercialization [1]

Core Viewpoint - Fengshan Group (603810) clarifies that its main business remains focused on the production, research, and sales of raw medicines and formulations, despite media reports linking the company to the "solid-state battery" concept [1] Business Operations - The company’s main business has not changed, and its subsidiary Fengshan Quannuo primarily sells lithium-ion electrolytes, with sodium-ion electrolytes accounting for a relatively small proportion of sales [1] - As of the first half of 2025, sodium-ion electrolyte sales are expected to represent only 0.01% of the company’s consolidated revenue [1] Research and Development - The recent important research results published by Professor Zhang Qiang's team from Tsinghua University are not related to the research and development project commissioned by the company [1] - The collaboration with Tsinghua University is still in the preliminary research and development phase, with a small contract amount, and the technical development project is scheduled to last until December 31, 2028, indicating significant uncertainty regarding future research outcomes and commercialization [1]